mProX™ Human EPHB4 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Kinase Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Cynthia
Verified Customer
Timothy
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 EphB4 protein expression in human lung cancer cell lines.
Immunoblotting panels of NSCLC and SCLC cell lines to measure the expression of the EphB4 protein. The expression of ephrin-B2 in NSCLC cell lines was also evaluated. The prostate cancer cell line PC3 was included as a positive control, while the immortalized, non-cancerous lung cell line BEAS-2B was employed as a control in this instance.
Ref: Ferguson, Benjamin D., et al. "The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target." PloS one 8.7 (2013): e67668.
Pubmed: 23844053
DOI: 10.1371/journal.pone.0067668
Research Highlights
Chen, Yinnan, Hongmei Zhang, and Yanmin Zhang. "Targeting receptor tyrosine kinase EphB4 in cancer therapy." Seminars in Cancer Biology. VolThis review covers the information on inhibitors of EphB4 kinase activity, examines the structure and function of the EphB4 receptor, and assesses its potential as a target for anticancer therapy. In conclusion, EphB4 represents a difficult yet intriguing cancer treatment target.
Chen, Yinnan, Hongmei Zhang, and Yanmin Zhang. "Targeting receptor tyrosine kinase EphB4 in cancer therapy." Seminars in Cancer Biology. Vol. 56. Academic Press, 2019.. 56. Academic Press, 2019.
Pubmed:
28993206
DOI:
10.1016/j.semcancer.2017.10.002
The ephrin (EFN) ligands of EPH kinases, the biggest family of receptor tyrosine kinases, are also molecules found on the cell surface. This study provides proof that the regulation of blood pressure is influenced by EPHB4 on vascular smooth muscle cells (VSMCs).
Wang, Yujia, et al. "EPHB4 protein expression in vascular smooth muscle cells regulates their contractility, and EPHB4 deletion leads to hypotension in mice." Journal of Biological Chemistry 290.22 (2015): 14235-14244.
Pubmed:
25903126
DOI:
10.1074/jbc.M114.621615